Trials / Conditions / Neuroblastoma, Recurrent, Refractory
Neuroblastoma, Recurrent, Refractory
4 registered clinical trials studyying Neuroblastoma, Recurrent, Refractory — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma NCT06751134 | Nanjing Children's Hospital | Phase 1 |
| Recruiting | Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma NCT06674265 | Marzieh Ebrahimi | Phase 1 |
| Completed | Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors NCT02644460 | Emory University | Phase 1 |
| Available | Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors NCT06872489 | Second Life Therapeutics | — |